Compare XNCR & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XNCR | MD |
|---|---|---|
| Founded | 1997 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2013 | 1996 |
| Metric | XNCR | MD |
|---|---|---|
| Price | $33.57 | $30.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 7 |
| Target Price | ★ $43.83 | $30.08 |
| AVG Volume (30 Days) | ★ 1.5M | 644.4K |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.36 | ★ 263.03 |
| EPS | N/A | ★ 1.43 |
| Revenue | $125,576,000.00 | ★ $1,913,849,000.00 |
| Revenue This Year | $58.19 | $2.82 |
| Revenue Next Year | N/A | $2.13 |
| P/E Ratio | ★ N/A | $20.93 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $10.38 | $17.23 |
| 52 Week High | $40.60 | $33.74 |
| Indicator | XNCR | MD |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 52.34 |
| Support Level | $22.80 | $30.24 |
| Resistance Level | $33.60 | $33.74 |
| Average True Range (ATR) | 2.08 | 1.06 |
| MACD | -0.54 | -0.27 |
| Stochastic Oscillator | 35.21 | 14.46 |
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.